. Markedly perturbed hematopoiesis in acid ceramidase deficient mice.
Acid ceramidase (ACDase) is ubiquitous and catalyzes the degradation of ceramide. ACDase and ceramides have been implicated in many disorders, including cancer, obesity, diabetes, inflammation, and neurodegenerative diseases. [1] [2] [3] Deficiencies in ACDase activity lead to Farber disease, but the specific role of this reaction in hematopoiesis has not been elucidated. We previously reported that Asah1 P361R/P361R mice have enlarged hematopoietic organs with leukocytosis, specifically neutrophilia and monocytosis, along with an excess of macrophages. 4 Here we establish that the organ enlargement is due to a gradual accumulation of foamy macrophages, which destroys the tissue architecture. Lymphoid progenitors in the BM and thymus of Asah1 P361R/P361R mice were severely reduced over time and myeloid progenitors were increased. Both progenitor populations were not intrinsically altered by ceramide accumulation, and, importantly, were able to reconstitute a WT mouse without inducing Farber disease.
Due to the rarity of patients diagnosed with Farber disease and their shortened lifespan, hematopoietic defects have only been described superficially. Case reports have mentioned some hematological manifestations, but they have presented inconsistently.
These manifestations include hepatosplenomegaly, enlargement and calcification of axillary lymph nodes (LN), peripheral blood leukocytosis, anemia, thrombocytopenia, and occasional nucleated RBCs. [5] [6] [7] [8] Most Farber patients present with subcutaneous nodules that may contain foamy histiocytes.
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We first sought to determine the cause of hematopoietic organ enlargement in our murine model of ACDase deficiency. Surprisingly, the 3-12 fold enlargement of the hematopoietic organs was not due to an increase in total recoverable cells ( Table 1) . The cell number in the BM, spleen, and thymus was actually reduced by 40-85%, and the cell 3 number in the LN was not significantly different. This decline in cell number occurs precipitously between week 5 and 9, near the end of the lifespan of the animal (data not shown). Instead, the hematopoietic organ enlargement was due to foamy macrophages.
An increase of large, unstained (pale) areas could be detected in 9 week-old Asah1 P361R/P361R animals in H&E stained sections ( Figure 1A) . These areas were B220-CD3-Mac-2+, suggesting cells of the myeloid lineage. These Mac-2+ cells were much larger in size than lymphocytes or Mac-2+ macrophages in WT BM and were consistent with foamy macrophages described in other LSDs. 10, 11 However, they were not "sea blue" after May-Grunwald and Giemsa staining, as described in Niemann-Pick disease.
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These macrophages were also F4-80-CD23-, and could bind IgM (data not shown). From 5 to 9 weeks such foamy macrophages increased in size and numbers (data not shown).
Histiocytic infiltrations have been found in biopsies of the liver, spleen, BM, lungs, thymus, LN, heart, spine, and peritoneal fluid of Farber patients. 6, 9, 13, 14 Further, the age of onset of dermal nodules (filled with histiocytes) has been suggested to correlate with life expectancy. 15 Antonarakis et al. describe a patient with normal PB counts initially that rapidly succumbed to the disorder as the PB counts increased; post-mortem analysis revealed massive histiocytic infiltration in organs. 6 The macrophage infiltration into tissues was so severe in our model that the architecture of the organs was altered. While WT thymuses showed distinctive cortex and medulla, no such architecture could be detected in sections from Asah1 P361R/P361R mice after 5 weeks of age ( Figure 1A ). Flow cytometry analyses revealed a time-dependent and precipitous decline of the CD4+ CD8+ T cell populations in the thymuses of Asah1 P361R/P361R mice from more than 77% in WT mice to less than 9% in mice, as assessed in vitro, appeared unaffected. B cell progenitors from 9-week-old mice maintained the capacity to respond to IL-7 stimulation in vitro (data not shown). it is not from a disproportionate increase of BFU-E (Figure 2A ). Instead these cell may be from the liver: Asah1 P361R/P361R livers contained many more myeloid CFCs than control livers at 5 weeks, with the difference gradually decreasing at 7 and 9 weeks ( Figure 2B ).
Extramedullary hematopoiesis has been noted in one very severe Farber disease patient that died 3 days after birth, 9 and would be consistent with emergent granulopoiesis observed during inflammation. Indeed, an accumulation of granulocytes was seen in the thymuses, LNs, and spleens of our Asah1 P361R/P361R mice as determined by Mac-1 and Gr-1 staining (data not shown).
Interestingly, there was an increase in total myeloid progenitor cell colonies seen in BM from Asah1 P361R/P361R mice at 5, 7, and 9 weeks ( Figure 2B ). The results of the CFC assay were recapitulated by flow analyses of lineage-Sca1+ cKit+ (LSK) cells;
Homozygous BM at 9 weeks had an increase in LSK cells. The difference in colony numbers in the CFC assays in samples originating from Asah1 P361R/P361R mice was smaller at 9 weeks compared to 5 and 7 weeks. Spleen myeloid progenitors were decreased in Asah1 P361R/P361R mice only at 7 weeks but, like the BM, the differentiation potential was similar to cells from WT controls (Figure 2A-B Figure 2D ), maintained a normal weight (Table 1) , and did not develop leukocytosis (data not shown). The spleen, LN, liver, and thymus sizes were reduced to normal WT sizes ( Table 1 ). The total amount of cells recovered from the BM, spleen, and thymus of BMT mice was greater than in control WT or Asah1
animals. Additionally, these organs were not filled with foamy Mac-2+ macrophages (data not shown). The single thymus that was found had a normal proportion of CD4+ CD8+ T cells ( Figure 1B) . Similarly, B cell progenitors were present at normal levels ( Figure 1E ). Together, these data suggest that Asah1 P361R/P361R hematopoietic cells alone are not sufficient to induce Farber disease in a WT environment. Alternatively, WT tissues transferred low levels of functional ACDase to the donor Asah1 P361R/P361R cells through mannose-6-phosphate receptor-mediated uptake. 
